Also categorized in BoardMoves:
Pfizer Spinoff Zoetis Takes Pershing Square's Doyle Onto Board
x hide permanently

Prevail Therapeutics Announces Appointment of Morgan Sheng, Ph.D., to Board of Directors

New York business news

 Prevail Therapeutics Inc. (Nasdaq: PRVL), a biotechnology company developing potentially disease-modifying AAV-based gene therapies for patients with neurodegenerative diseases, today announced the appointment of Morgan Sheng, Ph.D., to its Board of Directors...

Mentions: Nasdaq Prevail Therapeutics Inc Morgan Sheng